These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1392392)

  • 1. Further evidence of elevated bone resorption in Ullrich-Turner syndrome by measuring urinary galactosyl-hydroxylysine.
    Schönau E; Kruse K; de Bernard B; Moro L
    Acta Paediatr; 1992 Aug; 81(8):633-4. PubMed ID: 1392392
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary excretion of galactosyl-hydroxylysine is a marker of growth in children.
    Rauch F; Schnabel D; Seibel MJ; Remer T; Stabrey A; Michalk D; Schönau E
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1295-300. PubMed ID: 7714103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers for detecting bone metastases in patients with breast cancer.
    Moro L; Gazzarrini C; Crivellari D; Galligioni E; Talamini R; de Bernard B
    Clin Chem; 1993 Jan; 39(1):131-4. PubMed ID: 8419037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactosyl hydroxylysine and deoxypyridinoline: a methodological comparison.
    Bettica P; Baylink DJ; Moro L
    Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):459-65. PubMed ID: 8399787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactosyl hydroxylysine in assessment of Paget's bone disease.
    Michalsky M; Stepan JJ; Wilczek H; Formankova J; Moro L
    Clin Chim Acta; 1995 Jan; 234(1-2):101-8. PubMed ID: 7758208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum galactosyl hydroxylysine as a biochemical marker of bone resorption.
    Al-Dehaimi AW; Blumsohn A; Eastell R
    Clin Chem; 1999 May; 45(5):676-81. PubMed ID: 10222355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between body composition and the urinary excretion of deoxypyridinoline and galactosyl-hydroxylysine in children and adolescents.
    Fricke O; Land C; Beccard R; Semler O; Stabrey A; Schoenau E
    J Bone Miner Metab; 2009; 27(6):689-97. PubMed ID: 19526303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary hydroxylysine and hydroxylysyl glycosides excretion in patients with Turner's syndrome.
    Larizza D; Lorini R; Franchini M; Tenni R; Salvatoni A; Severi F
    Horm Metab Res; 1985 Aug; 17(8):432-3. PubMed ID: 4054834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared.
    Bettica P; Moro L; Robins SP; Taylor AK; Talbot J; Singer FR; Baylink DJ
    Clin Chem; 1992 Nov; 38(11):2313-8. PubMed ID: 1424129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactosylhydroxylysine and pyridinium cross links in monitoring the bone response to hormone replacement therapy.
    Marabini R; Sirtori P; Chionna R; Barzizza L; Rubinacci A
    J Endocrinol Invest; 1996 Mar; 19(3):154-8. PubMed ID: 8743280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary beta-1-galactosyl-0-hydroxylysine (GH) as a marker of collagen turnover of bone.
    Moro L; Pozzi Mucelli RS; Gazzarrini C; Modricky C; Marotti F; de Bernard B
    Calcif Tissue Int; 1988 Feb; 42(2):87-90. PubMed ID: 3127029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview.
    Simsek B; Karacaer O; Karaca I
    Chin Med J (Engl); 2004 Feb; 117(2):291-5. PubMed ID: 14975218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ullrich-Turner syndrome: neurodevelopmental changes from childhood through adolescence.
    Ross JL; Stefanatos G; Roeltgen D; Kushner H; Cutler GB
    Am J Med Genet; 1995 Jul; 58(1):74-82. PubMed ID: 7573160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion levels of hydroxylysine glycosides in osteoporotic patients.
    Yoshihara K; Mochidome N; Hara T; Osada S; Takayama A; Nagata M
    Biol Pharm Bull; 1994 Jun; 17(6):836-9. PubMed ID: 7951149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of hydroxylysine and its glycosides in Alport's syndrome and several other glomerulopathies.
    Schröder CH; Monnens LA; van Lith-Zanders HM; Trijbels JM; Veerkamp JH; Langeveld JP
    Nephron; 1986; 44(2):103-7. PubMed ID: 3774073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High predictivity of galactosyl-hydroxylysine in urine as an indicator of bone metastases from breast cancer.
    Moro L; Gazzarrini C; Modricky C; Rovis L; de Bernard B; Galligioni E; Crivellari D; Morassut S; Monfardini S
    Clin Chem; 1990 May; 36(5):772-4. PubMed ID: 2337988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noonan syndrome: a case report.
    Nirmal T; Muthu MS; Arranganal P
    J Indian Soc Pedod Prev Dent; 2001 Jun; 19(2):77-9. PubMed ID: 11692827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic method for measuring hydroxylysine glycosides and their ratio in urine as a possible marker of human bone collagen breakdown.
    Grazioli V; Casari E; Murone M; Bonini PA
    J Chromatogr; 1993 May; 615(1):59-66. PubMed ID: 8340463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of free hydroxylysine, peptide-bound hydroxylysine and hydroxylysyl glycosides in physiological conditions.
    Askenasi R
    Clin Chim Acta; 1975 Feb; 59(1):87-92. PubMed ID: 1122650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic preparation of galactosyl-hydroxylysine, a specific bone collagen marker.
    Moro L; Battista C; Modricky C; Rovis L; De Bernard B; Traldi P; Lubrano G; Marotti F
    J Chromatogr; 1989 May; 490(2):285-92. PubMed ID: 2768402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.